Title of article :
Cinnamaldehyde improves methamphetamine-induced spatial learning and memory deficits and restores ERK signaling in the rat prefrontal cortex
Author/Authors :
Etemad, Leila Pharmaceutical Research Center - Pharmaceutical Technology Institute - Mashhad University of Medical Sciences - Mashhad, Iran , Saeed, Mohammad School of Pharmacy - Mashhad University of Medical Sciences - Mashhad, Iran , Ghadiri, Ameneh Department of Internal Medicine and Medical Specialties - Sapienza University of Rome - Rome, Italy , Hadizadeh, Farzin Department of Medicinal Chemistry - School of Pharmacy - Mashhad University of Medical Sciences - Mashhad, Iran , Attaranzadeh, Armin Milad Infertility Center - Imam Reza Hospital - Mashhad University of Medical Sciences - Mashhad, Iran , Sadat Alavi, Mohaddeseh Division of Neurocognitive Sciences - Psychiatry and Behavioral Sciences Research Center - Mashhad University of Medical Sciences - Mashhad, Iran
Abstract :
Methamphetamine is a stimulant compound that penetrates readily into the central
nervous system. Repeated exposure to methamphetamine leads to damage in the dopaminergic
and serotonergic axons of selected brain regions. Previous studies showed that cinnamaldehyde
improved memory impairment in animals. In the present study, we aimed to elucidate the effects of
cinnamaldehyde on methamphetamine-induced memory impairment in rats.
Materials and Methods: Male Wistar rats received methamphetamine (10 mg/kg, intraperitoneally)
for 7 days. Thirty minutes before each injection, animals were given cinnamaldehyde (20, 40, or 80
mg/kg) or rivastigmine (1 mg/kg). The spatial learning and memory were examined using the Morris
water maze test. The expression of extracellular signal-regulated kinase (ERK) phosphorylation in the
frontal cortex and hippocampus was also detected by immunohistochemical method.
Results: Administration of methamphetamine increased the latency to find the platform in the learning
phase, while administration of cinnamaldehyde (40 mg/kg) or rivastigmine before methamphetamine
reversed the increased latency. Administration of cinnamaldehyde, at the dose of 40 mg/kg with
methamphetamine, increased the time and distance traveled in the target quadrant in comparison
with the amphetamine group. Moreover, the methamphetamine and cinnamaldehyde-treated group
had higher expression of phosphorylated ERK1/2 in the prefrontal cortex in comparison with the
methamphetamine-treated animals.
Conclusion: The present data demonstrated that repeated METH administration impaired cognitive
performance through the ERK pathway and decreased the phosphorylation of ERK1/2 in the
prefrontal cortex while administration of cinnamaldehyde restored both effects. Accordingly,
cinnamaldehyde may be a valuable therapeutic tool for the treatment of cognitive deficits associated
with methamphetamine consumption.
Keywords :
Cinnamaldehyde , ERK1 - 2 , Learning deficit , Memory deficit , Methamphetamine
Journal title :
Astroparticle Physics